Datar Cancer Genetics

Datar Cancer Genetics


Emerging Therapies Explained: Blood test for brain tumours

Date – Dec. 2023


Read More

Datar Cancer Genetics and Cromwell Hospital’s Second Opinion Service

Date – Oct. 17, 2023

Cromwell Hospital, a world-leading private hospital in London, is working with Datar Cancer Genetics as a trusted second opinion partner.

Read More

Sir Ian Botham: I’ve never been in the dressing room with any form of racism

Date – Aug. 10, 2023

Lord Ian Botham talks not just about racism but also the value of early cancer detection as he recently took the multi-cancer detection solution Trucheck.

Read More

US FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Inaccessible Brain Tumors

Date – Jan. 2, 2023

Datar Cancer Genetics now has three Breakthrough Designations granted by the USFDA, including liquid biopsies for breast and prostate cancer detection.

Read More

Blood test which spots ‘nearly every case of cancer’ before it spreads, will improve early treatment

Date – Oct. 28, 2022

The Trucheck blood test can identify 70 types of cancer, with the company hoping it can be rolled out across the NHS

Read More

'Game Changer' Blood Test Detects Breast Cancer

Date – July 24, 2022

‘Game-changer’ blood test detects breast cancer earlier than X-rays, study shows.

Read More

Landmark Liquid Biopsy Study

Date – July 13, 2022

Landmark Liquid Biopsy Study Shows Accurate Detection of Early-Stage Breast Cancer.

Read More

The London Clinic

Date – April 11, 2022

Datar Cancer Genetics enters into partnership with The London Clinic to offer enhanced cancer testing services

Read More

FDA - Prostate Cancer

Date – February 14, 2022

Datar’s TriNetra-Prostate Blood Test Gets FDA Breakthrough Designation.

Read More

South Africa

Date – February 2, 2022

Groundbreaking high-sensitivity cancer screening test arriving in SA ahead of World Cancer Day.

Read More


Date – December 7, 2021

Virtus Group announces partnership with Datar Cancer Genetics for personalized precision oncology solutions in Kuwait.

Read More

FDA - Breast Cancer

Date – November 19, 2021

US FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed by Datar Cancer Genetics.

Read More

The Healthcare Technology Report

Date – October 19, 2021

The Top 25 Women Leaders in Biotechnology of 2021 (Swati Deshpande – Datar Cancer Genetics)

Read More


Date – July 13, 2021

UK – National Institute for Health and Care Excellence (NICE) issues MedTech Innovation Briefing on ‘Trublood-Prostate’ for Precision Non-Invasive Prostate Cancer Diagnosis Described by Experts as a ‘Game Changer’.

Read More